The Department of Translational Hematology and Oncology Research (THOR) conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.

Department News


Concurrent Chemotherapy and Antibiotic Use Associated with Epithelial Ovarian Cancer Outcomes

Findings from a new retrospective study reveal that caution should be practiced when prescribing antibiotics to patients as antibiotic therapy is associated with decreased overall survival among women with the ovarian cancer.

Read More


Combining Genomics and Mathematics Helps Personalize Radiation Therapy for Lung Cancer

Rather than a one-size-fits-all approach, new technology from Dr. Scott provide opportunity to choose personalized radiation dose to improve outcomes and reduce toxicity.

Read More


Cancer Researchers Identify Potential New Class of Drugs to Treat Blood and Bone Marrow Cancers

Drs. Maciejewski and Jha developed a small molecule that selectively targeted and effectively eliminated cancer cells with a certain genetic mutation in preclinical models of myeloid leukemia, while simultaneously granting survival advantage to healthy cells.

Read More

More News